145 related articles for article (PubMed ID: 37877275)
1. Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi.
Lantz AM; Cottrell ML; Corbett AH; Chinula L; Kourtis AP; Nelson JAE; Tegha G; Hurst S; Gajer P; Ravel J; Haddad LB; Tang JH; Nicol MR
AIDS; 2023 Nov; 37(14):2185-2190. PubMed ID: 37877275
[TBL] [Abstract][Full Text] [Related]
2. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
[TBL] [Abstract][Full Text] [Related]
3. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
[TBL] [Abstract][Full Text] [Related]
4. Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial.
Kourtis AP; Wiener J; Hurst S; Nelson JAE; Cottrell ML; Corbett A; Chinula L; Msika A; Haddad LB; Tang JH
J Acquir Immune Defic Syndr; 2019 Jun; 81(2):163-165. PubMed ID: 31095006
[TBL] [Abstract][Full Text] [Related]
5. Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexposure Prophylaxis.
Nicol MR; Eneh P; Nakalega R; Kaiser T; Kabwigu S; Isingel E; Beksinska M; Sykes C; Fowler MG; Brown TT; Staley C; Kiweewa Matovu F
Clin Infect Dis; 2020 Apr; 70(8):1717-1724. PubMed ID: 31131846
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.
Kourtis AP; Haddad L; Tang J; Chinula L; Hurst S; Wiener J; Ellington S; Nelson JA; Corbett A; De Paris K; King CC; Hosseinipour M; Hoffman IF; Jamieson DJ
Contemp Clin Trials; 2017 Jan; 52():27-34. PubMed ID: 27836505
[TBL] [Abstract][Full Text] [Related]
7. Endogenous Hormones and Antiretroviral Exposure in Plasma, Cervicovaginal Fluid, and Upper-Layer Packed Cells of Malawian Women Living with HIV.
Nicol MR; Cottrell ML; Corbett AH; Chinula L; Tegha G; Stanczyk FZ; Hurst S; Kourtis AP; Tang JH
AIDS Res Hum Retroviruses; 2020 Aug; 36(8):641-646. PubMed ID: 32390454
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women.
Dumond JB; Nicol MR; Kendrick RN; Garonzik SM; Patterson KB; Cohen MS; Forrest A; Kashuba AD
Clin Pharmacokinet; 2012 Dec; 51(12):809-22. PubMed ID: 23044523
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
[TBL] [Abstract][Full Text] [Related]
10. Impact of contraceptive initiation on vaginal microbiota.
Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
[TBL] [Abstract][Full Text] [Related]
11. Genital Inflammation Is Not Associated With Decreased Vaginal Tenofovir Concentrations in Women Taking Oral PrEP.
Morris S; Cottrell M; Rawlings SA; Peterson S; Karris M; Pacheco D; Chaillon A; Kay A; Chow K; Anderson PL; Gianella S; Blumenthal J
J Acquir Immune Defic Syndr; 2022 Apr; 89(4):390-395. PubMed ID: 35202047
[TBL] [Abstract][Full Text] [Related]
12. Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
Bunjun R; Ramla TF; Jaumdally SZ; Noël-Romas L; Ayele H; Brown BP; Gamieldien H; Harryparsad R; Dabee S; Nair G; Onono M; Palanee-Phillips T; Scoville CW; Heller KB; Baeten JM; Bosinger SE; Burgener A; Passmore JS; Jaspan H; Heffron R
Clin Infect Dis; 2022 Nov; 75(11):2000-2011. PubMed ID: 35941737
[TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi.
Zia Y; Tang JH; Chinula L; Tegha G; Stanczyk FZ; Kourtis AP
Contraception; 2019 Nov; 100(5):402-405. PubMed ID: 31374188
[TBL] [Abstract][Full Text] [Related]
14. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.
Morrison CS; Hofmeyr GJ; Thomas KK; Rees H; Philip N; Palanee-Phillips T; Nanda K; Nair G; Onono M; Mastro TD; Lind M; Heffron R; Edward V; Deese J; Beksinska M; Beesham I; Stringer JSA; Baeten JM; Ahmed K;
AIDS Res Hum Retroviruses; 2020 Aug; 36(8):632-640. PubMed ID: 32394723
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU
Front Immunol; 2021; 12():760504. PubMed ID: 34956191
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant.
Tanko RF; Bunjun R; Dabee S; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Harryparsad R; Happel AU; Gamieldien H; Qumbelo Y; Sinkala M; Scoville CW; Heller K; Baeten JM; Bosinger SE; Burgener A; Heffron R; Jaspan HB; Passmore JAS
J Infect Dis; 2022 Sep; 226(5):907-919. PubMed ID: 35263421
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
[TBL] [Abstract][Full Text] [Related]
18. Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIV
Srinivasan P; Zhang J; Dinh CT; Teller RS; McNicholl JM; Kiser PF; Herold BC; Smith JM
J Med Primatol; 2017 Aug; 46(4):129-136. PubMed ID: 28748662
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.
Kwara A; Delong A; Rezk N; Hogan J; Burtwell H; Chapman S; Moreira CC; Kurpewski J; Ingersoll J; Caliendo AM; Kashuba A; Cu-Uvin S
Clin Infect Dis; 2008 Mar; 46(5):719-25. PubMed ID: 18220480
[TBL] [Abstract][Full Text] [Related]
20. Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring.
Thurman AR; Ravel J; Gajer P; Marzinke MA; Ouattara LA; Jacot T; Peet MM; Clark MR; Doncel GF
Front Cell Infect Microbiol; 2022; 12():799501. PubMed ID: 35350436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]